Company · CIK 0001625297 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Indivior Pharmaceuticals, Inc. · INDV
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 PForm 4 → | Aug 27, 4:00 pm EDT | Woodrow D AndersonChief Accounting Officer | 1,500 | $35.69 | $53,535 | 27,638 | +5.74% | |
| Aug 5, 2026 PForm 4 → | Aug 5, 4:52 pm EDT | Woodrow D AndersonChief Accounting Officer | 1,500 | $36.28 | $54,420 | 26,138 | +6.09% | |
| Jul 10, 2026 SForm 4 → | Jul 13, 4:31 pm EDT | Christian HeidbrederChief Scientific Officer | 18,586 | $41.14 | $764,628 | 209,337 | −8.15% | 10b5-1 |
| Jun 22, 2026 FMForm 4 → | Jun 23, 5:24 pm EDT | Joseph CiaffoniChief Executive Officer, Director | 1,879,452 | $38.32 | $23,472,878 | 790,330 | — | |
| Jun 11, 2026 SForm 4 → | Jun 12, 4:10 pm EDT | Christian HeidbrederChief Scientific Officer | 18,586 | $38.06 | $707,383 | 227,923 | −7.54% | 10b5-1 |
| Jun 8, 2026 SForm 4 → | Jun 10, 6:04 am EDT | Ryan PreblickChief Financial Officer | 36,000 | $37.70 | $1,357,200 | 284,751 | −11.2% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 MForm 4 → | Jun 23, 5:24 pm EDT | Joseph CiaffoniChief Executive Officer, Director | 1,266,903 | — | — | 0 | — |